ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,402, issued on Dec. 16, was assigned to Kymera Therapeutics Inc. (Watertown, Mass.).
"IRAK4 degraders and uses thereof" was invented by Haojing Rong (Watertown, Mass.) and Bradley Enerson (Watertown, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method of treating autoimmune/autoinflammatory diseases and hematological malignancies in a subject."
The patent was filed on Sept. 1, 2023, under Application No. 18/459,675.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=...